Address
BiosparQ B.V.
Galileïweg 8
2333 BD Leiden
The Netherlands
Contact
Nellie Schipper+31 650414461
schipper@biosparq.nl
Website
Cirrus D20: DigiTOF technology
Enabling prescription of targeted therapeutics / antibiotics for common infectious diseases
To help turn back AMR, the Cirrus D20 has been developed, allowing identification of microorganisms direct from patient samples without the need to culture
Empowering first and second line health care professionals to prescribe targeted antibiotics for common infectious diseases
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Validation
- Market entry
- Research
- Development
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Government
- Academia
- Institute
- NGO
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
Infectious disease area:
Geographic origin:
Having expertise in the area of manufacturing, medical applications, business development
BiosparQ is a high-tech start-up company (15 fte) located at the Bio Science parc in Leiden
Other: expertise in the area of manufacturing, medical applications, business developme
